You have no items in your shopping cart.
Recombinant SARS-CoV-2/COVID-19 Omicron Nucleocapsid protein Protein
Description
Images & Validation
−
Key Properties
−| Source | SARS-CoV-2 |
|---|---|
| Purity | ≥ 95% as determined by SDS-PAGE |
Storage & Handling
−| Disclaimer | For research use only |
|---|
Alternative Names
−Similar Products
−SARS-CoV-2 (Covid-19) nucleocapsid (N) (Omicron, B.1.1.529) Recombinant Protein [orb1671227]
CLIA, ELISA, LF, WB
> 95% pure by SDS-PAGE. Ligand affinity purified.
This recombinant protein contains full length of Covid-19 Omicron nucleocapsid protein (carrying mutations of P13L, Δ31-33, R203K, G204R) with a MW of 46.2 kDa.
E. coli
0.1 mgSARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Nucleocapsid Recombinant Protein [orb1231020]
>90% as determined by SDS-PAGE
46.31 kDa
E. coli
0.1 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Quick Database Links
Documents Download
Request a Document
Protocol Information
Recombinant SARS-CoV-2/COVID-19 Omicron Nucleocapsid protein Protein (orb1562517)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review